Long-term biological effects in sickle cell disease: insights from a post-crizanlizumab study

Affiliations

• ¹ East Carolina University Brody School of Medicine, Greenville, NC, USA.
• ² Duke University Medical Center, Durham, NC, USA.
• ³ University of North Carolina Health Care, Chapel Hill, NC, USA.
• ⁴ University of Illinois at Chicago, Chicago, IL, USA.
• ⁵ Virginia Commonwealth University, Richmond, VA, USA.
• ⁶ University of Alabama at Birmingham, Birmingham, AL, USA.
• ⁷ Brigham and Women's Hospital, Boston, MA, USA.
• ⁸ Center for Cancer and Blood Disorders, Bethesda, MD, USA.
• ⁹ University of Arkansas for Medical Sciences, Little Rock, AR, USA.
• ¹⁰ Thomas Jefferson University, Philadelphia, PA, USA.
• ¹¹ Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.
• ¹² Our Lady of the Lake-Mary Bird Perkins Cancer Center, Baton Rouge, LA, USA.
• ¹³ Indiana Hemophilia and Thrombosis Center, Indianapolis, IN, USA.
• ¹⁴ University of Texas Health Science Center at Houston, Houston, TX, USA.
• ¹⁵ The Ohio State University Wexner Medical Center, Columbus, OH, USA.
• ¹⁶ Children's Specialty Center of Nevada, Las Vegas, NV, USA.
• ¹⁷ Children's Hospital of Orange County, Orange, CA, USA.
• ¹⁸ University of Colorado Denver School of Medicine, Denver, CO, USA.
• ¹⁹ Children's Hospital of Michigan, Detroit, MI, USA.
• ²⁰ Sickle Cell Center, Medical College of Georgia, Augusta, GA, USA.